HK1089946A1 - Non-pegylated long-circulating liposomes - Google Patents

Non-pegylated long-circulating liposomes

Info

Publication number
HK1089946A1
HK1089946A1 HK06110458.8A HK06110458A HK1089946A1 HK 1089946 A1 HK1089946 A1 HK 1089946A1 HK 06110458 A HK06110458 A HK 06110458A HK 1089946 A1 HK1089946 A1 HK 1089946A1
Authority
HK
Hong Kong
Prior art keywords
liposomes
phospholipid
sucrose
ammonium sulphate
hydration
Prior art date
Application number
HK06110458.8A
Other languages
English (en)
Inventor
Gautam Vinod Daftary
Srikanth Annappa Pai
Sangeeta Hanurmesh Rivankar
Original Assignee
Bsv Res And Dev Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bsv Res And Dev Private Ltd filed Critical Bsv Res And Dev Private Ltd
Publication of HK1089946A1 publication Critical patent/HK1089946A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK06110458.8A 2002-12-31 2006-09-20 Non-pegylated long-circulating liposomes HK1089946A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1101MU2002 2002-12-31
PCT/IN2003/000424 WO2004058140A2 (en) 2002-12-31 2003-12-31 Non-pegylated long-circulating liposomes

Publications (1)

Publication Number Publication Date
HK1089946A1 true HK1089946A1 (en) 2006-12-15

Family

ID=32500467

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06110458.8A HK1089946A1 (en) 2002-12-31 2006-09-20 Non-pegylated long-circulating liposomes

Country Status (19)

Country Link
EP (1) EP1435231B8 (ru)
JP (1) JP5355842B2 (ru)
KR (2) KR101133084B1 (ru)
CN (1) CN1756533B (ru)
AT (1) ATE453381T1 (ru)
AU (1) AU2003303368B2 (ru)
BR (1) BR0317882A (ru)
CA (1) CA2511464C (ru)
DE (1) DE60330745D1 (ru)
DK (1) DK1435231T3 (ru)
EA (1) EA008930B1 (ru)
ES (1) ES2337563T3 (ru)
HK (1) HK1089946A1 (ru)
IL (1) IL169364A (ru)
MX (1) MXPA05007102A (ru)
NZ (1) NZ540778A (ru)
PT (1) PT1435231E (ru)
WO (1) WO2004058140A2 (ru)
ZA (1) ZA200504850B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008250518B2 (en) * 2007-05-16 2013-09-12 Ktb Tumorforschungsgesellschaft Mbh Low-viscous anthracycline formulation
US9968583B2 (en) 2009-03-30 2018-05-15 Eisai R & D Management Co., Ltd. Method of manufacture of liposome composition
PE20120923A1 (es) * 2009-03-30 2012-08-27 Eisai Randd Man Co Ltd Composiciones farmaceuticas comprendiendo liposomas que contiene eribulina o una sal del mismo
WO2012118376A1 (en) * 2011-03-01 2012-09-07 To-Bbb Holding B.V. Advanced active liposomal loading of poorly water-soluble substances
CN107106703A (zh) * 2014-11-25 2017-08-29 纳米生物技术公司 药物组合物、其制备和用途
CA3038657A1 (en) * 2016-09-27 2018-04-05 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of dna-damaging agents and dna-pk inhibitors
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
CN116570775A (zh) * 2023-05-16 2023-08-11 万瑞飞鸿(北京)医疗器材有限公司 一种药物涂层、血管支架及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
WO1985000968A1 (en) * 1983-09-06 1985-03-14 Health Research, Inc. Liposome delivery method for decreasing the toxicity of an antitumor drug
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
CA1270198C (en) * 1984-08-08 1990-06-12 Marcel B Bally ENCAPSULATION OF ANTINEOPLASTIC AGENTS IN LIPOSONES
US4920016A (en) 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
JPH0720857B2 (ja) 1988-08-11 1995-03-08 テルモ株式会社 リポソームおよびその製法
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
US6132763A (en) 1988-10-20 2000-10-17 Polymasc Pharmaceuticals Plc Liposomes
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
ES2208946T3 (es) * 1996-08-23 2004-06-16 Sequus Pharmaceuticals, Inc. Liposomas que contienen un compuesto de cisplatino.
DK1121102T3 (da) * 1998-09-16 2003-08-11 Alza Corp Liposomindesluttede topoisomeraseinhibitorer
KR20000061075A (ko) * 1999-03-23 2000-10-16 린 중친 리포솜의 응집을 방지하기 위한 방법 및 조성물
GB0111279D0 (en) * 2001-05-10 2001-06-27 Nycomed Imaging As Radiolabelled liposomes

Also Published As

Publication number Publication date
KR101133084B1 (ko) 2012-04-04
JP5355842B2 (ja) 2013-11-27
EA200500850A1 (ru) 2006-02-24
PT1435231E (pt) 2010-04-08
EP1435231A1 (en) 2004-07-07
ES2337563T3 (es) 2010-04-27
AU2003303368B2 (en) 2010-06-17
EA008930B1 (ru) 2007-08-31
KR20110075051A (ko) 2011-07-05
KR101171045B1 (ko) 2012-08-03
CN1756533A (zh) 2006-04-05
WO2004058140A2 (en) 2004-07-15
DE60330745D1 (de) 2010-02-11
IL169364A0 (en) 2007-07-04
ATE453381T1 (de) 2010-01-15
KR20050088233A (ko) 2005-09-02
EP1435231B1 (en) 2009-12-30
ZA200504850B (en) 2006-08-30
JP2006513189A (ja) 2006-04-20
AU2003303368A1 (en) 2004-07-22
MXPA05007102A (es) 2005-08-26
CA2511464C (en) 2011-08-23
CN1756533B (zh) 2010-06-16
DK1435231T3 (da) 2010-04-26
WO2004058140B1 (en) 2004-12-16
IL169364A (en) 2012-05-31
EP1435231B8 (en) 2010-03-03
CA2511464A1 (en) 2004-07-15
NZ540778A (en) 2008-04-30
WO2004058140A3 (en) 2004-10-28
BR0317882A (pt) 2005-12-13

Similar Documents

Publication Publication Date Title
HK1089946A1 (en) Non-pegylated long-circulating liposomes
MY143051A (en) Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
AU4010701A (en) Methods and kits for locally administering an active agent to an interstitial space of a host
ES2051740T3 (es) Un procedimiento para la formacion de pequeñas vesiculas unilaminares que encapsulan un antibiotico polienico.
EA200300457A1 (ru) Кристаллический моногидрат, способ его получения и его применение для получения лекарственного средства
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
AR002262A1 (es) Composicion y metodo para el tratamiento de enfermedades fungales de las unas y un vendaje adaptado para la administracion topica de medicacion a lasunas.
WO2004110346A3 (en) Sustained release of antiinfectives
CY1105707T1 (el) Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
WO2005011653A3 (en) Pyridazine derivatives and their use as therapeutic agents
WO2007003948A3 (en) Core 2 glcnac-t inhibitors
IT8812585A0 (it) Preparato, in particolare preparato cosmetico antisolare, nonche' metodo per l'introduzione di una sostanza attiva nella pelle
NO180147C (no) Fremgangsmåte for fremstilling av HDLC eller et liposom innbefattende et polyen-antisopp-antibiotikum og et lipid
PL324549A1 (en) Novel derivatives of isoxazole and crotonic acid, method of obtaining them, pharmaceutic agent and application of such derivatives in production of pharmaceutic agents
IL158155A (en) Use of erythropoietin for the preparation of a medicament to ameliorate chemotherapy-induced toxicity
WO2003059246A3 (en) Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
BR9610316A (pt) Composto processo para a produção e uso do mesmo processo para o tratamento de doença das vias aéreas e composição farmacêutica
CO4960654A1 (es) Metodo para el tratamiento de enfermedades fisiologicas relacionadas con el uso o con las secuelas provocadas por el uso de la cocaina u otros estimulantes psicomotores
BR9917389B1 (pt) formulaÇÕes tàpicas compreendendo agentes de penetraÇço na pele e o uso das mesmas.
CA2241825A1 (en) New monofunctionalized edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
FR2793490B1 (fr) Procede de preparation du (1r,2s,4r)-(-)-2-[(2'-{n,n- dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]- bicyclo[2.2.1]-heptane et ses sels d'addition d'acide pharmaceutiquement acceptables
EP1301203A4 (en) VACCINE COMPRISING AS ACTIVE AGENT ANNO-OLISACCHARIDE OF ACYL-GLYCERYL-PHOSPHATIDYLINOSITOL IMMUNOGENE
WO2003000232A3 (en) Method for preparation of vesicles loaded with immunostimulator y oligodeoxynucleotides
JPH0251517U (ru)
HUP0004647A3 (en) Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151231